Ambey Laboratories

AMBEY

Q: How strong is Ambey Laboratories balance sheet?

Balance sheet of Ambey Laboratories is strong.But short term working capital might become an issue for this company.

Q: Is the debt of Ambey Laboratories increasing or decreasing?

The debt of Ambey Laboratories is decreasing.Latest debt of Ambey Laboratories is ₹23.82 Crs as of Sep-24.This is less than Mar-24 when it was ₹29.23 Crs.

Q: Is Ambey Laboratories stock expensive?

Ambey Laboratories is not expensive.Latest PE of Ambey Laboratories is 12.54, while 3 year average PE is 23.48. Also latest EV/EBITDA of Ambey Laboratories is 0 while 3yr average is 11.52.

Price

Micro Cap

₹100 Cr.

New to Zerodha? Sign-up for free.

Ambey Laboratories specializes in manufacturing agrochemical products, particularly '2,4-D base chemicals', focusing on quality and adherence to Environmental, Health, and Safety regulations in the chemical industry.

Ambey Laboratories specializes in manufacturing agrochemical products, particularly '2,4-D base che… More

Low

37.20

52W Range

High

97.20

12.89

Sector PE

22.67

P/B

Div.Yield

ROE

24.5%

EBIDTA

ROCE

17.84

EPS

New to Zerodha? Sign-up for free.

Share Price
Financials
Revenue mix
Shareholdings
Peers
Forensics

This data is currently unavailable for this company.

Summary
Profit & Loss
Balance sheet
Cashflow

View Detailed Summary

This data is currently unavailable for this company.

Yearly | Quarterly

(In Cr.)

(In Cr.)
This data is currently unavailable for this company.

Financial Ratio's

(In %)

Detailed P&L Report

(In Cr.)

Detailed Balance Sheet

Financial Year (In Cr.)

Detailed Cash Flow

Product wise
Location wise

AMBEY
Revenue Mix

Latest

Historic

This data is currently unavailable for this company.

AMBEY
Revenue Mix

Latest

Historic

This data is currently unavailable for this company.

More Info

Shareholdings

Holders

Detailed Shareholdings

This data is currently unavailable for this company.

Peers

Detailed Peers

Forensics

View Detailed Forensics

Recent events

News
Corporate Actions

Ambey Laboratories To Raise 30 Mln Rupees Via NCDs

Jan 30, 2025

Ambey Laboratories Approves Raising Of Funds Of Upto 31 Mln Rupees

Oct 22, 2024

This data is currently unavailable for this company.

More Micro Cap Ideas

See similar 'Micro' cap companies with recent activity

Promoter Buying

Companies where the promoters are bullish

Detailed List

Capex

Companies investing on expansion

Detailed List

Superstar Investor

Companies where well known investors have invested

Detailed List

Popular questions

Business
Financials
Share Price
Shareholdings

What does Ambey Laboratories do?

Ambey Laboratoriesis engaged in the business of manufacturing of agrochemical products for the protecting of crops. The company manufactures and supplies ‘2,4-D base chemicals’ with an emphasis on quality and strict compliance with Environmental, Health, and Safety (EHS) regulations, within the chemical industry.

Who are the competitors of Ambey Laboratories?

Ambey Laboratories major competitors are Aristo Bio-Tech&Lis, Aimco Pesticide, Crop Life Science, Super Crop Safe, Bhaskar Agrochem, Sikko Industries, Phyto Chem (India). Market Cap of Ambey Laboratories is ₹97 Crs. While the median market cap of its peers are ₹86 Crs.

Is Ambey Laboratories financially stable compared to its competitors?

Ambey Laboratories seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Does Ambey Laboratories pay decent dividends?

The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Ambey Laboratories latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

How has Ambey Laboratories allocated its funds?

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

How strong is Ambey Laboratories balance sheet?

Balance sheet of Ambey Laboratories is strong. But short term working capital might become an issue for this company.

Is the profitablity of Ambey Laboratories improving?

The profit is oscillating. The profit of Ambey Laboratories is ₹6.98 Crs for TTM, ₹7.72 Crs for Mar 2024 and ₹5.24 Crs for Mar 2023.

Is the debt of Ambey Laboratories increasing or decreasing?

The debt of Ambey Laboratories is decreasing. Latest debt of Ambey Laboratories is ₹23.82 Crs as of Sep-24. This is less than Mar-24 when it was ₹29.23 Crs.

Is Ambey Laboratories stock expensive?

Ambey Laboratories is not expensive. Latest PE of Ambey Laboratories is 12.54, while 3 year average PE is 23.48. Also latest EV/EBITDA of Ambey Laboratories is 0 while 3yr average is 11.52.

Has the share price of Ambey Laboratories grown faster than its competition?

There is not enough historical data for the companies share price.

Is the promoter bullish about Ambey Laboratories?

Promoters seem to be bullish about the company. Latest quarter promoter holding is 70.11% and last quarter promoter holding is 69.9%.

Are mutual funds buying/selling Ambey Laboratories?

There is Insufficient data to gauge this.

AMBEY

Share Price

Financials

Revenue mix

Shareholdings

Peers

Forensics

Summary

Profit & Loss

Balance sheet

Cashflow

Product wise

Location wise

Recent events

News

Corporate Actions

Ambey Laboratories To Raise 30 Mln Rupees Via NCDs

Ambey Laboratories Approves Raising Of Funds Of Upto 31 Mln Rupees

More Micro Cap Ideas

Promoter Buying

Capex

Superstar Investor

Popular questions

Business

Financials

Share Price

Shareholdings

What does Ambey Laboratories do?

Who are the competitors of Ambey Laboratories?

Is Ambey Laboratories financially stable compared to its competitors?

Does Ambey Laboratories pay decent dividends?

How has Ambey Laboratories allocated its funds?

How strong is Ambey Laboratories balance sheet?

Is the profitablity of Ambey Laboratories improving?

Is the debt of Ambey Laboratories increasing or decreasing?

Is Ambey Laboratories stock expensive?

Has the share price of Ambey Laboratories grown faster than its competition?

Is the promoter bullish about Ambey Laboratories?

Are mutual funds buying/selling Ambey Laboratories?